| Biomarker ID | 1235 |
| PMID | 24183365 |
| Year | 2014 |
| Biomarker | Prostate Stem Cell Antigen (PSCA) |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways inlcude: MAPK15 human kinase ARCHS4 coexpression, MAP3K19 human kinase ARCHS4 coexpression, RIPK4 human kinase ARCHS4 coexpression, ERN2 human kinase ARCHS4 coexpression |
| Experiment | Gleason Score 6 Vs Gleason Score 8 |
| Type of Biomarker | Diagnostic |
| Cohort | 114 prostate cancers (PCa), 21 High Grade Pros- tatic Intraepithelial Neoplasias (HGPIN) and 50 samples of benign prostate tissue - All from Iranian origin were taken for the study. 45 with Gleason Score 6, 50 with Gleason Score 7 and 5 with Gleason Score 8 |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | Immunohistochemistry |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |